Intriguingly, in contrast to the previous findings, ACAT1 inhibition has been shown to enhance the anti-tumor effect of CD8+ T cells by increasing free cholesterol in the cytoplasm, which promotes membrane synthesis [172]. Here, CD8A is linked to neoplasm.